| Nov 15 |
Exploring Three High Growth Tech Stocks in the United States
|
| Nov 12 |
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
|
| Nov 8 |
Travere Therapeutics prices $125M equity offering
|
| Nov 8 |
Travere Therapeutics Announces Pricing of Public Offering of Common Stock
|
| Nov 7 |
Travere Therapeutics announces proposed offering of common stock
|
| Nov 7 |
Travere Therapeutics Announces Proposed Public Offering of Common Stock
|
| Nov 4 |
Travere Therapeutics to Present at Upcoming Investor Conferences
|
| Nov 1 |
Travere Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Oct 31 |
Travere Therapeutics, Inc. (TVTX) Q3 2024 Earnings Call Transcript
|
| Oct 31 |
Travere Therapeutics beats Q3 revenue estimates
|
